// App-Quantinova.ai

: PATIENTS WITH HIGHER BODY MASS INDEX TREATED WITH DIRECT / NON VITAMIN K DEPENDENT ANTICOAGULANTS (DOAC / NOAC) EXPERIENCE WORSE CLINICAL OUTCOMES

Researchers

Presenter

  • Marko Lucijanic

Principal Investigators

  • Ivana Jurin

  • Hrvoje Jurin

  • Boris Starcevic

  • Marko Skelin

  • Anton Glasnovic

  • Irzal Hadzibegovic

Medical Centers

  • Pathology, Clinical Hospital Dubrava, Zagreb, Croatia

  • Clinical Hospital, Zagreb, Croatia

  • Univeristy Hospital Centre Zagreb, Zagreb, Croatia

  • General Hospital Sibenik,Sibenik,Croatia

  • School of Medicine, University of Zagreb, Zagreb, Croatia

Locations

  • Croatia

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

Disease

  • Arrhythmia

  • Venous thrombosis

  • Obesity

  • Stroke

Biomarkers

  • Fibrillin-1

  • Body mass index

Drug/Treatment

  • rivaroxaban

  • Pradax

  • apixaban

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved